thus, it inhibits the ceramide synthase activity disrupting sphingolipid metabolism and inducing cell death in both plants and animal cells (Yanagawa et al., 2017
People with type 2 diabetes have higher baseline rates of anxiety and depression compared to the general population, making it difficult to distinguish medication effects from underlying psychological comorbidity
Head-to-head trials directly comparing mazdutide and retatrutide have not been conducted, so any comparison has to be made across separate trials with different populations, dosing schedules, and durations not a true apples-to-apples comparison
Lactic acidosis, though rare (fewer than 10 cases per 100,000 patient-years), represents the most serious potential complication
Considerations when switching Currently, there is no NICE or Medicines and Healthcare products Regulatory Agency guidance that specifies how to switch between tirzepatide and semaglutide
17 Screening should be considered in patients with risk factors, and diagnostic testing should be considered in those with suspected clinical manifestations